Am J Transplant, Volume 5, Suppl 3 Archives - Page 38 of 170 - ATC Abstracts

2015 American Transplant Congress
Kidney Transplantation from Expanded Criteria Deceased Donors With Terminal Acute Kidney Injury
J. Hwang,¹ M.-H. Kim,¹ K. Jun,¹ S. Ahn,¹ S. Kim,¹ S. Park,¹ S. Kim,² J. Kim,¹ C. Yang,² I. Moon.¹
¹Surgery, The catholic University of Korea, Seoul, Korea; ²Internal Medicine, The catholic iniversity of Korea, Seoul, Korea.
We investigated clinical outcomes of kidney transplantation (KT) from deceased donors with terminal acute kidney injury (AKI) defined acute kidney injury network (AKIN) criteria and…
2015 American Transplant Congress
Alemtuzumab Induction Is Associated With a Lower Risk of Early Rehospitalization After Kidney Transplant
G. Dube,¹ D. Tsapepas,² Y. Coppleson,³ L. Ratner,⁴ D. Cohen,¹ S. Mohan.¹
¹Medicine, Columbia University Medical Center, New York, NY; ²Pharmacy, New York-Presbyterian Hospital, New York, NY; ³Quality and Patient Safety, New York-Presbyterian Hospital, New York, NY; ⁴Surgery, Columbia University Medical Center, New York, NY.
Early rehospitalizations within the first 30 days (R-30D) are common after kidney transplant. R-30D are costly and associated with an increased risk of graft failure…
2015 American Transplant Congress
Does Infection Impact On Tacrolimus Blood Levels in Kidney Transplant Recipients?
N. Kanaan,¹ C. Percy,¹ Z. Hassoun,² M. Mourad,³ C. Beguin,⁴ M. De Meyer,³ E. Goffin.¹
¹Nephrology, Cliniques Universitaires Saint Luc, Brussels, Belgium; ²Gastroenterology, Cliniques Universitaires Saint Luc, Brussels, Belgium; ³Abdominal Surgery and Transplantation, Cliniques Universitaires Saint Luc, Brussels, Belgium; ⁴Medical Information and Statistics, Cliniques Universitaires Saint Luc, Brussels, Belgium.
Background Tacrolimus (Tac) is the cornerstone of immunosuppressive therapy in kidney transplant recipients. It is metabolized by members of the cytochrome p450 (CYP) 3A subfamily…
2015 American Transplant Congress
Efficacy and Safety of Desensitization Protocol Based On Rituximab Plus MMF in ABO-Incompatible Kidney Transplantation Without Splenectomy
K. Takahashi,¹ K. Saito,² S. Takahara,³ S. Fuchinoue,⁴ T. Yagisawa,⁵ A. Aikawa,⁶ Y. Watarai,⁷ N. Yoshimura,⁸ K. Tanabe,⁴ K. Morozumi,⁹ M. Shimazu.¹⁰
¹Niigata Organ Transplant Foundation, Niigata, Japan; ²Graduate School of Medical ＆ Dental Sciences, Niigata University, Niigata, Japan; ³Osaka University Graduate School of Medicine, Osaka, Japan; ⁴Tokyo Women's Medical University, Tokyo, Japan; ⁵Jichi Medical University Hospital, Tochigi, Japan; ⁶Toho University, Faculty of Medicine, Tokyo, Japan; ⁷Nagoya Daini Red Cross Hospital, Aichi, Japan; ⁸Kyoto Prefectural University of Medicine, Kyoto, Japan; ⁹Masuko Memorial Hospital, Aichi, Japan; ¹⁰Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
Purpose: An open-label, single arm, multicenter clinical study has been conducted in Japan for prospective examination of the efficacy and safety of desensitization protocol with…
2015 American Transplant Congress
Descriptive Analysis of Patients Who Travel Away from Home for Orthotopic Liver Transplantation
C. Frenette,¹ A. Harper,³ J. Waalen,² J. Fisher,¹ R. Schaffer,¹ A. Baquerizo,¹ C. Marsh.¹
¹Department of Organ Transplant, Scripps Clinic/Green Hospital, La Jolla, CA; ²Department of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla, CA; ³United Network for Organ Sharing, United Network for Organ Sharing, Richmond, VA.
Aim: Given the current geographic disparities in access to liver transplantation (OLT), there is a segment of the population that may travel to different areas…
2015 American Transplant Congress
Evaluation of the Effects of N-Acetylcysteine Treatment in Adult Liver Transplant Recipients
E. Aldag, S. Farrell, R. Pedersen, A. Sahajpal, J. Clendenon, V. Gunabushanam, D. Kramer.
Aurora St Luke's Medical Center, Milwaukee, WI.
Background: N-acetylcysteine (NAC) has been used in post-orthotopic liver transplant (OLT) patients for the proposed mechanism of preventing tissue damage of the newly transplanted organ…
2015 American Transplant Congress
ABO-Incompatible Liver Transplantation for Severe Hepatitis B Patients
J. Zhou, W. Ju, X. Yuan, X. Jiao, D. Wang, X. Zhu, X. He.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Objectives: Effect of ABO-incompatible liver transplantation on severe hepatitis B (SHB) patients is still unclear. Herein, we described 22 successful cases of patients with SHB…
2015 American Transplant Congress
A Tool for Predicting Long Term Risks of Kidney Donation
S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
¹Department of Medicine, University of Minnesota, Minneapolis, MN; ²Department of Surgery, University of Minnesota, Minneapolis, MN.
Background:The evidence linking kidney donation to a slightly increased risk of ESRD has now been accepted. The underlying causes of ESRD majority of donors who…
2015 American Transplant Congress
The Effects of Various Cardiac Preservation Solutions on Survival After Heart Transplantation
C. Evans, K. Rajagopal, P. Sanchez, S. Rahimpour, F. Cheema, R. Pierson III, B. Griffith, S. Pham.
Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD.
Purpose: The optimal cardiac preservation solution is still debated. The purpose of this study is to determine whether the type of cardiac preservation solution has…
2015 American Transplant Congress
Increased Use of Donors After Cardiac Death (DCD) in Pancreas Transplantation: A Safe and Effective Way to Increase a Single Center Program Activity
M. Marquez, G. Sapisochin, J. Laurence, A. Barbas, M. Dib, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattral.
Multi-Organ Transplant, University Health Network, Toronto, ON, Canada.
The SRTR database shows that DCD donors are rarely used for pancreas transplantation in the USA (< 3% in 2010 -2012). This low rate likely…